Clincosm LogoSign in Get a demo

Biliary Tract Cancer

Showing 51 - 75 of 152
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer Trial in Shanghai (Capecitabine combined with lenvatinib and tislelizumab)

Recruiting
  • Biliary Tract Cancer
  • Capecitabine combined with lenvatinib and tislelizumab
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 23, 2022

Hepatocellular Carcinoma, Biliary Tract Cancer, Cirrhosis Trial in United States (Blood samples)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Blood samples
  • Jacksonville, Florida
  • +3 more
Mar 29, 2022

Biliary Tract Cancer Trial in Worldwide (NUC-1031, Gemcitabine, Cisplatin)

Terminated
  • Biliary Tract Cancer
  • Tucson, Arizona
  • +124 more
Mar 16, 2022

Biliary Tract Cancer Trial in Seoul ('SMT-NK' Inj (allogeneic Natural Killer cell), Pembrolizumab Injection [Keytruda])

Completed
  • Biliary Tract Cancer
  • 'SMT-NK' Inj (allogeneic Natural Killer cell)
  • Pembrolizumab Injection [Keytruda]
  • Seoul, Korea, Republic of
  • +1 more
Mar 28, 2022

Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer Trial in Beijing, Jinan, Shanghai (TT-00420, Combination Product:

Not yet recruiting
  • Advanced Solid Tumor
  • +10 more
  • Beijing, China
  • +3 more
Feb 14, 2022

Biliary Tract Cancer Trial in United States (CPI 613, Gemcitabine, Cisplatin)

Recruiting
  • Biliary Tract Cancer
  • CPI 613
  • +2 more
  • Tucson, Arizona
  • +9 more
Feb 18, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Biliary Tract Cancer Trial in United States (telotristat ethyl)

Terminated
  • Biliary Tract Cancer
  • telotristat ethyl
  • Gilbert, Arizona
  • +13 more
Jan 14, 2022

Patients With Cholangiocarcinoma and Gallbladder Cancer

Recruiting
  • Biliary Tract Cancer
  • +2 more
    • Herlev, Copenhagen, Denmark
      Herlev & Gentofte Hospital
    Dec 21, 2021

    Biliary Tract Cancer Trial in Shanghai (ZKAB001 5mg/kg, Capecitabine)

    Enrolling by invitation
    • Biliary Tract Cancer
    • Shanghai, China
      Renji Hospital Affiliated to School of Medicine, Shanghai Jiaoto
    Jan 10, 2022

    Depression, Fatigue, Stage IIA Colorectal Cancer Trial in Winston-Salem, Nashville (Laboratory Biomarker Analysis, Questionnaire

    Completed
    Has Results
    • Depression
    • +20 more
    • Laboratory Biomarker Analysis
    • +5 more
    • Winston-Salem, North Carolina
    • +1 more
    Jan 5, 2022

    Biliary Tract Cancer Trial in Xuzhou (Surufatinib Toripalimab)

    Recruiting
    • Biliary Tract Cancer
    • Surufatinib Toripalimab
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Dec 22, 2021

    Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

    Recruiting
    • Metastatic Breast Carcinoma
    • +13 more
    • 68GaNOTA-Anti-HER2 VHH1
    • Brussels, Brussel, Belgium
      Uz Brussel
    Dec 17, 2021

    Biliary Tract Cancer, PD-1 Antibody, Gemox Trial in Shanghai (PD-1+Lenvatinib+GEMOX)

    Recruiting
    • Biliary Tract Cancer
    • +3 more
    • Shanghai, China
      Zhongshan hospital
    Dec 11, 2021

    Colorectal Cancer Not MSI-H or MMR-deficient, GIST, Oesophageal or Gastric Carcinoma Trial in France (Phase 1 : Regorafenib,

    Recruiting
    • Colorectal Cancer Not MSI-H or MMR-deficient
    • +9 more
    • Phase 1 : Regorafenib
    • +4 more
    • Bordeaux, France
    • +6 more
    Dec 6, 2021

    Biliary Tract Cancer Trial in Essen, Pamplona (mFOLFOX6, Atezolizumab and Bevacizumab)

    Recruiting
    • Biliary Tract Cancer
    • mFOLFOX6, Atezolizumab and Bevacizumab
    • Essen, NRW, Germany
    • +1 more
    Nov 16, 2021

    Biliary Tract Cancer, Cholangiocarcinoma Trial in Nanjing (SHR-1210+GEMOX)

    Completed
    • Biliary Tract Cancer
    • Cholangiocarcinoma
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Oct 27, 2021

    Biliary Tract Cancer Trial in China (RC48-ADC)

    Recruiting
    • Biliary Tract Cancer
    • Hefei, Anhui, China
    • +16 more
    Sep 14, 2021

    Biliary Tract Cancer Trial in Riyadh (FOLFIRINOX)

    Recruiting
    • Biliary Tract Cancer
    • FOLFIRINOX
    • Riyadh, Saudi Arabia
      king Faisal Specialist Hospital and Research Center
    Aug 30, 2021

    Gastrointestinal Cancer, Biliary Tract Cancer Trial in Taichung, Tainan, Taipei (D07001-softgel capsules)

    Terminated
    • Gastrointestinal Cancer
    • Biliary Tract Cancer
    • D07001-softgel capsules
    • Taichung, Taiwan
    • +3 more
    Aug 25, 2021

    Biliary Tract Cancer Trial in Worldwide (Varlitinib, Capecitabine, Placebo (for Varlitinib))

    Completed
    Has Results
    • Biliary Tract Cancer
    • Gilbert, Arizona
    • +20 more
    Jul 12, 2021

    Hepatocellular Carcinoma, Biliary Tract Cancer Trial in Seoul (Nivolumab or pembrolizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • Biliary Tract Cancer
    • Nivolumab or pembrolizumab
    • Seoul, Korea, Republic of
      Changhoon Yoo
    Jul 21, 2021

    Biliary Tract Cancer Trial in Guangzhou, Guanzhou (HA121-28 tablets)

    Recruiting
    • Biliary Tract Cancer
    • HA121-28 tablets
    • Guangzhou, Guangdong, China
    • +1 more
    Jun 23, 2021

    Response to Treatment in Bile Duct Cancer: ACABi PRONOBIL Study

    Not yet recruiting
    • Biliary Tract Cancer
      • (no location specified)
      Jun 15, 2021

      Cholangiocarcinoma, Biliary Tract Cancer, Targeted Therapy Trial in Beijing (Lenvatinib)

      Completed
      • Cholangiocarcinoma
      • +2 more
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Jun 2, 2021